# Phase 4 Canonical Implementation Status

**Date:** 2026-07-27  
**Status:** `PHASE4_LIVE_DEVELOPMENT_COMPLETED_FORMAL_BENCHMARK_PENDING`  
**Scope:** Canonical architecture and 20-case live development benchmark complete; formal test has not been run.

## Implemented and Verified

- An isolated canonical package at `src/agent_system/phase4/`, with no imports from legacy rule-based evaluators.
- An observable closed loop: validation -> planning -> prognostic tool -> evidence tool -> synthesis -> verification -> revision or safe abstention.
- A frozen OOF prognostic tool for Phase 4 benchmark cases. It is explicitly labelled `PHASE3A_FROZEN_OOF_EVALUATION_ONLY` and cannot be used for new patients or described as a deployable model.
- Exact model-value fidelity checks, citation-ID checks, forbidden-claim checks, bounded revision, and safe abstention.
- An injected structured-JSON LLM interface configured at runtime with `PHASE4_LLM_API_KEY`, `PHASE4_LLM_MODEL`, and optionally `PHASE4_LLM_BASE_URL`; credentials are not serialized and the legacy LLM configuration is not used.
- Deterministic fault fixtures for evidence-tool unavailability and malformed LLM output.
- A machine-readable architecture gate at `experiments/phase4/readiness/PHASE4_ARCHITECTURE_GATE.json`.

## Verification Result

- Canonical Phase 4, benchmark, fault, ablation, and formal-runner tests: 29 passed.
- Supported canonical plus prognostic-engine suite: 149 passed, 5 skipped, 0 failed in the locked Python 3.12 environment.
- The frozen OOF SHA-256 remains `7b21074e208a563bc99b6a0a8c458f076a5ab333612e65ce2659cd9d6571228f`.
- Gate result: success `true`; formal-benchmark-ready `false`.

## Explicitly Not Yet Complete

1. Explicit authorization of the projected external-token expenditure.
2. Disjoint 100-case formal benchmark, four ablations, and 30-case-per-fault evaluation.
3. Direct external validation of M4 remains unavailable; the completed cross-platform microarray validation applies only to the separate frozen M2T gene-only transport model.

## Live development benchmark update (2026-07-27)

- A 20-case development set and a disjoint 100-case reserved formal set were created.
- The development evidence set contains 12 PubMed records, 48 sentence-level passages, and 96 deterministic support/mismatch pairs.
- Live B0-B4 development execution completed with 100 system records and 136 LLM calls.
- Descriptive verified task success: B1 0/20, B2 17/20, B3 13/20, B4 20/20; B0 is a non-agent reference and cannot satisfy the evidence-grounded endpoint.
- B4 recovered one invalid plan and two evidence-synthesis failures through observable retry traces.
- These development results are excluded from confirmatory claims and the main Figure 2.
- Full report: `docs/PHASE4_DEVELOPMENT_BENCHMARK_REPORT_20260727.md`.

No Phase 4 paper-performance claim may be made until these items are completed. The offline template policy exists only to test control flow and is excluded from formal results.
